XML 22 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Assets    
Cash and cash equivalents $ 1,333,000,000 $ 1,253,000,000
Receivables 142,000,000 142,000,000
Inventories:    
Leaf tobacco 940,000,000 941,000,000
Other raw materials 186,000,000 170,000,000
Work in process 647,000,000 560,000,000
Finished product 558,000,000 554,000,000
Inventory, net 2,331,000,000 2,225,000,000
Income taxes 167,000,000 461,000,000
Other current assets 326,000,000 263,000,000
Total current assets 4,299,000,000 4,344,000,000
Property, plant and equipment, at cost:    
Land and land improvements 309,000,000 302,000,000
Buildings and building equipment 1,442,000,000 1,437,000,000
Machinery and equipment 2,981,000,000 2,975,000,000
Construction in progress 218,000,000 165,000,000
Property, plant and equipment, at cost 4,950,000,000 4,879,000,000
Less accumulated depreciation 3,012,000,000 2,965,000,000
Property, plant and equipment, net 1,938,000,000 1,914,000,000
Goodwill 5,196,000,000 5,307,000,000
Other intangible assets, net 12,279,000,000 12,400,000,000
Investment in AB InBev 17,696,000,000 17,952,000,000
Investment in JUUL 12,800,000,000 0
Other assets 1,430,000,000 1,285,000,000
Total Assets 55,638,000,000 43,202,000,000
Liabilities    
Short-term borrowings 12,704,000,000 0
Current portion of long-term debt 1,144,000,000 864,000,000
Accounts payable 399,000,000 374,000,000
Accrued liabilities:    
Marketing 586,000,000 695,000,000
Employment costs 189,000,000 188,000,000
Settlement charges 3,454,000,000 2,442,000,000
Other 1,214,000,000 971,000,000
Dividends payable 1,503,000,000 1,258,000,000
Total current liabilities 21,193,000,000 6,792,000,000
Long-term debt 11,898,000,000 13,030,000,000
Deferred income taxes 5,172,000,000 5,247,000,000
Accrued pension costs 544,000,000 445,000,000
Accrued postretirement health care costs 1,749,000,000 1,987,000,000
Other liabilities 254,000,000 283,000,000
Total liabilities 40,810,000,000 27,784,000,000
Contingencies
Redeemable noncontrolling interest 39,000,000 38,000,000
Stockholders' Equity    
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued) 935,000,000 935,000,000
Additional paid-in capital 5,961,000,000 5,952,000,000
Earnings reinvested in the business 43,962,000,000 42,251,000,000
Accumulated other comprehensive losses (2,547,000,000) (1,897,000,000)
Cost of repurchased stock (931,903,722 shares at December 31, 2018 and 904,702,125 shares at December 31, 2017) (33,524,000,000) (31,864,000,000)
Total stockholders’ equity attributable to Altria 14,787,000,000 15,377,000,000
Noncontrolling interests 2,000,000 3,000,000
Total stockholders’ equity 14,789,000,000 15,380,000,000
Total Liabilities and Stockholders’ Equity $ 55,638,000,000 $ 43,202,000,000